COVID-19 could worsen cerebral amyloid angiopathy.

Dewisme, Julie; Lebouvier, Thibaud; Vannod-Michel, Quentin; Prevot, Vincent; Maurage, Claude-Alain

Dewisme, Julie; Lebouvier, Thibaud; Vannod-Michel, Quentin; Prevot, Vincent; Maurage, Claude-Alain.

Afiliação

Dewisme J; Development and Plasticity of the Neuroendocrine Brain, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
Lebouvier T; Alzheimer and Tauopathy, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
Vannod-Michel Q; Neuroradiology Department, Lille University, Medical Centre, Lille, France.
Prevot V; Development and Plasticity of the Neuroendocrine Brain, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
Maurage CA; Development and Plasticity of the Neuroendocrine Brain, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.

J Neuropathol Exp Neurol ; 82(9): 814-817, 2023 08 21.

Article em En | MEDLINE | ID: mdl-37428895

Assuntos

COVID-19; Angiopatia Amiloide Cerebral; Humanos; COVID-19/complicações; Angiopatia Amiloide Cerebral/complicações; Hemorragia Cerebral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article